Decline of mumps antibodies in Type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of Type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland

This publication has 27 references indexed in Scilit:

• VIRUS ANTIBODIES IN SERUM SPECIMENS FROM PATIENTS WITH MULTIPLE SCLEROSIS, FROM SIBLINGS, AND MATCHED CONTROLS. A FINAL REPORT*
  Acta Neurologica Scandinavica, 2009
• Risk of aseptic meningitis after measles, mumps,and rubella vaccine in UK children
  The Lancet, 1993
• Decreased antibody reactivity to Epstein‐Barr virus capsid antigen in type 1 (insulin‐dependent) diabetes mellitus
  APMIS, 1991
• HUMORAL IMMUNITY AGAINST VIRAL ANTIGENS IN TYPE 1 DIABETES: ALTERED IgA‐CLASS IMMUNE RESPONSE AGAINST COXSACKIE B4 VIRUS
  Acta Pathologica Microbiologica Scandinavica Series C: Immunology, 1986
• RAPID EFFECT ON ENDEMIC MEASLES, MUMPS, AND RUBELLA OF NATIONWIDE VACCINATION PROGRAMME IN FINLAND
  The Lancet, 1986
• Metabolic, Hormonal, and Immunological Alterations in Subjects with Antecedent Mumps Infection
  Experimental and Clinical Endocrinology & Diabetes, 1985
• Mumps Infection and Insulin-dependent Diabetes Mellitus (IDDM)
  Diabetes Care, 1984
• Relation of antecedent illness to development of diabetes in children.
  BMJ, 1980
• ISLET CELL ANTIBODIES IN CHILDREN WITH MUMPS INFECTION
  The Lancet, 1980
• Is mumps virus an etiologic factor in juvenile diabetes mellitus?: Preliminary report
  The Journal of Pediatrics, 1975